What is Gonadorelin?
Gonadorelin is a synthetic decapeptide prepared using solid-phase peptide synthesis. It is also known by name gonadotropin-releasing hormone. It is generally preferred for women who are missing menstrual periods due to low levels of gonadotropin-releasing hormone (GnRH) and for the treatment of female infertility.
Global Gonadorelin Market Outlook
Increasing cases of women's fertility and irregular periods are driving the demand of gonadorelin across the globe. Approvals by FDA for new therapies are anticipated to propel growth by the forecast. It has been predicted that the burden of infertility will remain high. One in every four couples in developing countries had been found to be affected by infertility. Increasing disorder and abnormality associated with ovary female fertility will fuel demand. According to Maternal Health Task Force, at least 50 million couples worldwide experience infertility, during the survey it is estimated that approximately 10.5% of women around the world experienced secondary infertility, and roughly 2% experienced primary infertility. GONAbreed, Factrel Injection, Fertagyl, and Cystorelin are gonadorelin products.
Global Gonadorelin Market Competitive Landscape
The "Global Gonadorelin Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such Ferring, Xuchang Shangke Chemical, Bachem, Aspen Oss, Shenzhen JYMed Technology, Toronto Research Chemicals, LKT Laboratories, Hemmo Pharmaceutical, Angle Bio Pharma and MercK. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1. INTRODUCTION OF GLOBAL GONADORELIN MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions
2. EXECUTIVE SUMMARY
3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources
4. GLOBAL GONADORELIN MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL GONADORELIN MARKET, BY TYPE
5.1. Overview
5.2. Nasal Spray
5.3. Injection
6. GLOBAL GONADORELIN MARKET, BY APPLICATION
6.1. Overview
6.2. Humans
6.3. Other Mammals
7. GLOBAL GONADORELIN MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia Pacific
7.5. Rest of the World
7.5.1. Latin America
7.5.2. Middle East & Africa
8. GLOBAL ATOSIBAN MARKET COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies
9. COMPANY PROFILES
9.1. Ferring
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
9.2. Xuchang Shangke Chemical
9.2.1. Overview
9.2.2. Financial Performance
9.2.3. Product Outlook
9.2.4. Key Developments
9.3. Bachem
9.3.1. Overview
9.3.2. Financial Performance
9.3.3. Product Outlook
9.3.4. Key Developments
9.4. Aspen Oss
9.4.1. Overview
9.4.2. Financial Performance
9.4.3. Product Outlook
9.4.4. Key Developments
9.5. Shenzhen JYMed Technology
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Outlook
9.5.4. Key Developments
9.6. Toronto Research Chemicals
9.6.1. Overview
9.6.2. Financial Performance
9.6.3. Product Outlook
9.6.4. Key Developments
9.7. LKT Laboratories
9.7.1. Overview
9.7.2. Financial Performance
9.7.3. Product Outlook
9.7.4. Key Developments
9.8. Hemmo Pharmaceutical
9.8.1. Overview
9.8.2. Financial Performance
9.8.3. Product Outlook
9.8.4. Key Developments
9.9. Angle Bio Pharma
9.9.1. Overview
9.9.2. Financial Performance
9.9.3. Product Outlook
9.9.4. Key Developments
9.10. MercK
9.10.1. Overview
9.10.2. Financial Performance
9.10.3. Product Outlook
9.10.4. Key Developments
10. Appendix
10.1. Related Reports
| Price : US$ 3500 | Date : Aug 2023 |
| Category : Healthcare and Pharmaceuticals | Pages : 145 |
| Price : US$ 3500 | Date : Aug 2023 |
| Category : Healthcare and Pharmaceuticals | Pages : 149 |
| Price : US$ 3500 | Date : May 2022 |
| Category : Healthcare and Pharmaceuticals | Pages : 120 |
| Price : US$ 3500 | Date : Jun 2022 |
| Category : Healthcare and Pharmaceuticals | Pages : 120 |
| Price : US$ 3500 | Date : Jun 2022 |
| Category : Healthcare and Pharmaceuticals | Pages : 120 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
Request Sample 
Request Discount 
Inquire Before Buy
